This study was done to show the outcome of the surgical evacuation of CSDH in patients with intractable thrombocytopenia (platelet count which did not reach 100,000 per microliter after platelet transfusions).
█ INTRODUCTION
C hronic subdural hematoma (CSDH) is a common situation in neurosurgical practice. The treatment of choice for a symptomatic chronic subdural hematoma is its urgent surgical evacuation (8) .
Evacuation of a chronic subdural hematoma is not a major neurosurgical operation as no major blood loss is expected and no prolonged general anesthesia is required. It can also be performed under local anesthesia.
The standard of practice nowadays is to administer prophylactic platelet transfusions before major neurosurgical operations if the platelet count is below the threshold of 100,000 per microliter to decrease the incidence of acute bleeding (6) . However, in emergency operations, the platelet count should be at least 80,000 per microliter.
Exclusion criteria:
-Patients with CSDH who did not undergo surgical evacuation.
-Patients with ethylenediaminetetraacetic acid (EDTA)-induced thrombocytopenia.
-Thrombocytopenic patients whose preoperative platelet counts reached 100,000 per microliter by platelet transfusions.
-Patients with decompensated liver cirrhosis and acute liver failure.
The clinical data were collected from the patients' charts and include; history of head trauma, associated medical diseases, the etiology of thrombocytopenia, the preoperative clinical state, laboratory findings, preoperative computed tomography (CT) scan findings, the preoperative preparation, time between admission and surgery, full operative details, postoperative management, any complications from surgery, follow-up CT scan findings and the progressive notes in the follow-up visits.
The neurological condition of the patients was preoperatively and postoperatively evaluated with the Markwalder's Neurological Grading System (Table I ) (7).
The type of CSDH was classified on CT scan as mixed density containing some acute blood, isodensity to the brain, or hypodensity to the brain. Clot volume was measured by multiplying the maximum extent in each of 3 orthogonal views and dividing by 2.
On admission, all patients started a prophylactic antiepileptic in the form of phenytoin (loading and maintenance doses) except in known hepatic patients who were started levetiracetam instead of phenytoin.
Patients received a prophylactic intravenous antibiotic (ceftriaxone) within one hour of the operation.
In the operating theater, patients received general anesthesia with a muscle relaxant. Prep was done using 7.5% Povidone Iodine for cleaning and 10% Povidone Iodine for painting.
Two linear scalp incisions down to bone were done on the maximal thickness of the subdural hematoma. One burr hole in each scalp incision was done with a diameter of at least 1.5 cm. Incision of the dura and washing the subdural space by warm saline was done till the wash becomes clear. One subgaleal drain for each scalp wound was inserted and then was removed two to three days post-op.
No subdural drain was used in any case.
The operated patients were flat in bed for 2 days after the operation then had a gradual elevation of the head.
All patients had received a preoperative platelet transfusion of 18 units of random donor pooled (RDP) platelets but did not reach the platelet count of 100,000 per microliter.
All patients received intraoperatively 6 units of RDP platelet transfusion and another 6 units postoperatively within 12 hours of surgery.
Follow-up cranial CT scan was done for all patients after 48 hours of the operation, after one month and after 6 months of surgery.
Follow-up period was at least 12 months after surgery (ranging from 12 months to 26 months)
█ RESULTS
Forty-one patients with symptomatic CSDH and intractable thrombocytopenia were included in this study.
The age of the patients in this study ranged from 28 to 84 years with a mean age of 59 years. Twenty-four patients (58.5%) were male. Thirty-four patients (82.9%) had a history of head trauma (apparently trivial trauma) within 6 weeks before admission, without any following alteration in consciousness.
Associated medical diseases and the etiology of thrombocytopenia are seen in Tables II and III. All patients had a prior history of platelet transfusion. All patients were not on any anti-platelets or anti-coagulants.
Thirty-three patients had isolated thrombocytopenia and eight patients had pancytopenia.
The platelet count on admission of the patients in this study ranged from 23,000 to 62,000 per microliter (Table IV) .
The type of CSDH was classified on CT scan as mixed density containing some acute blood, isodense to the brain, or hypodense to the brain. Twenty-three patients had mixed density CSDH, eleven patients had isodense CSDH, and seven patients had hypodense CSDH.
Clot volume ranged between 55 to 132 cm 3 with a mean volume of 81 cm 3 .
The mean thickness of the CSDH on the CT scan was 2.4 cm, ranging from 1.6 to 3.4 cm. The midline shift ranged between 0.6 mm to 2.3 cm with a mean shift of 1.4 cm.
CSDH was bilateral in 4 cases (9.7%).
Eight patients received packed RBCs transfusion to raise the hemoglobin to at least 10 gm/dl.
Nine patients received fresh frozen plasma (FFP) transfusions to decrease the international normalized ratio (INR) to at least 1.4.
All patients included in this study received preoperatively 6 units of RDP platelets to raise the platelet count and a new platelet count was done 30 minutes after the transfusion. This was repeated three times without correction of the platelet count to the cut-off value of 100,000 per microliter (Table IV) .
The surgical evacuation was decided with intraoperative and postoperative platelet transfusions. The immediate preoperative platelet count for the patients is listed in Table IV. The duration between admission and surgery ranged from 47 to 85 hours.
The duration of surgery (from skin incisions to skin closure) ranged between 51 minutes to 86 minutes with a mean duration of 55 minutes. All surgeries were uneventful.
The follow-up cranial CT scan, which was done 48 hours after the operation, showed a decrease in the size of the CSDH, decrease in midline shift with a variable amount of air in the subdural space and no acute subdural hematoma.
All operated patients improved clinically within few days after surgery.
Routine follow-up CT scan at one month after surgery showed no recurrence of CSDH, except in two patients who had recurrence of CSDH and had re-evacuation via another burr holes.
Routine follow-up CT scan after 6 months of surgery showed no recurrence of CSDH.
No postoperative symptomatic acute subdural hematoma or intracerebral hematoma occurred in any patient in this study.
No patient developed an infection within the surgical field during the whole period of follow-up.
Follow-up period was at least 12 months after surgery (ranging from 12 months to 26 months).
█ DISCUSSION
Platelets play a vital role in hemostasis. Platelet transfusion plays a significant value for thrombocytopenic patients in preventing hemorrhage. There are no randomized controlled trials on the exact platelet count which permits a safe cranial surgery, but there is an expert opinion to keep the preoperative platelet count at least 100,000/microliters.
The American Association of Blood Banks (AABB) in 2015 recommends platelet transfusion of up to a single unit of apheresis platelets or equivalent and added that extra doses are not more effective (3) . This dose may increase the platelet count by 60,000/microliter within a peak of one hour (1).
In this study, 41 thrombocytopenic patients had a surgical evacuation of their symptomatic CSDH. These patients received preoperative platelet transfusion but their thrombocytopenia was intractable i.e. their platelet count didn't reach 100,000 per microliter.
Although many thrombocytopenic patients respond appropriately after platelet transfusion, inadequate correction tends to occur and fail to produce a satisfactory response. This intractable thrombocytopenia leads to longer hospital stays and higher inpatient hospital costs (4, 5) .
All patients in this study improved clinically within few days after surgery, and the follow-up cranial CT scan, done 48 hours after the operation, showed a decrease in the size of the CSDH, and decrease in midline shift in all patients.
Two patients had a recurrence of CSDH after one month of surgery and had re-evacuation. The cause of recurrence was probably because of the plenty of septae in the CSDH.
No postoperative acute subdural hematoma or intracerebral hematoma occurred in any patient in this study. 
